The Strategy, Object And Transaction Of M&A In The Pharmathceutical Industry

First, the article outlines the status and future trends of global andChina’s pharmaceutical industry, and analyzes the M&A opportunities andcharacteristics in global pharmaceutical industry and in China. Then, thearticle analyzes the acquisition case study between Yunnan Walvax and Zerun,Hebei Daan, explained the current situation and the challenges of M&Aindustry in China. Companies can develop a successful acquisition strategy,assessment and screening acquisition targets, monitor and manage thetransaction of merger of these three stages to achieve successful goal.Meanwhile, the impact of M&A for the success of the three key factors: thetiming of acquisitions, the capability of M&A as well as the ability toapproach a combination of talent. Finally, M&A of Chinese enterprises tobecome a successful growth strategy, while Chinese enterprises are facing thebiggest gap is the lack of experience and skills; critical point is to establish aclear target in line with the company’s acquisition strategy, evaluatingacquisition targets also need attention should be focused on its businessmodel and operational efficiency of sustainability, effective post-mergerintegration is a key M&A activity.